These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22253906)

  • 1. Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.
    Takahashi K; Mizukami H; Kamata K; Inaba W; Kato N; Hibi C; Yagihashi S
    PLoS One; 2012; 7(1):e30134. PubMed ID: 22253906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition.
    Ramana KV; Willis MS; White MD; Horton JW; DiMaio JM; Srivastava D; Bhatnagar A; Srivastava SK
    Circulation; 2006 Oct; 114(17):1838-46. PubMed ID: 17030682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice.
    Yagihashi S; Mizukami H; Ogasawara S; Yamagishi S; Nukada H; Kato N; Hibi C; Chung S; Chung S
    J Pathol; 2010 Apr; 220(5):530-41. PubMed ID: 20112370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.
    Obrosova IG; Maksimchyk Y; Pacher P; Agardh E; Smith ML; El-Remessy AB; Agardh CD
    Int J Mol Med; 2010 Jul; 26(1):135-42. PubMed ID: 20514433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 deficiency increased susceptibility to lipopolysaccharide-induced acute renal injury.
    Lee DH; Park MH; Hwang CJ; Hwang JY; Yoon HS; Yoon DY; Hong JT
    Arch Toxicol; 2016 May; 90(5):1151-62. PubMed ID: 26055553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of Danhong injection on the lipopolysaccharide-stimulated systemic acute inflammatory reaction via multi-target strategy.
    Gao LN; Cui YL; Wang QS; Wang SX
    J Ethnopharmacol; 2013 Oct; 149(3):772-82. PubMed ID: 23954279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway.
    Wang S; Zeng M; Li B; Kan Y; Zhang B; Zheng X; Feng W
    Biomed Pharmacother; 2020 Sep; 129():110403. PubMed ID: 32574970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide Induces Chronic Kidney Injury and Fibrosis through Activation of mTOR Signaling in Macrophages.
    Chen H; Zhu J; Liu Y; Dong Z; Liu H; Liu Y; Zhou X; Liu F; Chen G
    Am J Nephrol; 2015; 42(4):305-17. PubMed ID: 26517816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.
    Chang KC; Ponder J; Labarbera DV; Petrash JM
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2853-61. PubMed ID: 24677107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase regulates doxorubicin-induced immune and inflammatory responses by activating mitochondrial biogenesis.
    Sonowal H; Saxena A; Qiu S; Srivastava S; Ramana KV
    Eur J Pharmacol; 2021 Mar; 895():173884. PubMed ID: 33482179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Luteolin on Lipopolysaccharide-Induced Acute Renal Injury in Mice.
    Xin SB; Yan H; Ma J; Sun Q; Shen L
    Med Sci Monit; 2016 Dec; 22():5173-5180. PubMed ID: 28029146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
    Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
    Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats.
    Sung JK; Koh JH; Lee MY; Kim BH; Nam SM; Kim JH; Yoo JH; Kim SH; Hong SW; Lee EY; Choi R; Chung CH
    Yonsei Med J; 2010 May; 51(3):385-91. PubMed ID: 20376891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.
    Ramana KV; Fadl AA; Tammali R; Reddy AB; Chopra AK; Srivastava SK
    J Biol Chem; 2006 Nov; 281(44):33019-29. PubMed ID: 16956889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages.
    Shoeb M; Yadav UC; Srivastava SK; Ramana KV
    Free Radic Biol Med; 2011 Nov; 51(9):1686-96. PubMed ID: 21856412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis.
    Zhao YL; Zhang L; Yang YY; Tang Y; Zhou JJ; Feng YY; Cui TL; Liu F; Fu P
    Chin Med J (Engl); 2016 May; 129(9):1100-7. PubMed ID: 27098797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response.
    Li CX; Ng KT; Shao Y; Liu XB; Ling CC; Ma YY; Geng W; Qi X; Cheng Q; Chung SK; Lo CM; Man K
    Ann Surg; 2014 Aug; 260(2):317-28. PubMed ID: 24699020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
    Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
    Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the α7nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration.
    Yang A; Wu CH; Matsuo S; Umene R; Nakamura Y; Inoue T
    Int Immunopharmacol; 2024 Sep; 138():112555. PubMed ID: 38943973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting Toll-like receptor 4 signaling pathway.
    Song J; Fan HJ; Li H; Ding H; Lv Q; Hou SK
    Eur J Pharmacol; 2016 Feb; 772():108-14. PubMed ID: 26698392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.